Short Term Results of Fibrin Gel Obtained from Cord Blood Units: A Preliminary in Vitro Study

Bioengineering
Panagiotis MallisEfstathios Michalopoulos

Abstract

Recent findings have shown that the fibrin gel derived from cord blood units (CBUs) play a significant role in wound healing and tissue regeneration. The aim of this study was to standardize the fibrin gel production process in order to allow for its regular use. CBUs (n = 200) were assigned to 4 groups according to their initial volume. Then, a two-stage centrifugation protocol was applied in order to obtain platelet rich plasma (PRP). The concentration of platelets (PLTs), white blood cells (WBCs) and red blood cells (RBCs) were determined prior to and after the production process. In addition, targeted proteomic analysis using multiple reaction monitoring was performed. Finally, an appropriate volume of calcium gluconate was used in PRP for the production of fibrin gel. The results of this study showed that high volume CBUs were characterized by greater recovery rates, concentration and number of PLTs compared to the low volume CBUs. Proteomic analysis revealed the presence of key proteins for regenerative medicine. Fibrin gel was successfully produced from CBUs of all groups. In this study, low volume CBUs could be an alternative source for the production of fibrin gel, which can be used in multiple regenerative medicine ap...Continue Reading

References

Dec 2, 2004·Biophysical Chemistry·Birger Blombäck, Niklas Bark
Apr 20, 2005·Advances in Protein Chemistry·John W Weisel
Sep 1, 2005·Transfusion·Paolo PerseghinGiovanni Paolini
May 9, 2006·Cancer Metastasis Reviews·Elena I Deryugina, James P Quigley
Aug 1, 2007·Journal of Thrombosis and Haemostasis : JTH·J W Weisel
Aug 29, 2007·Journal of Thrombosis and Haemostasis : JTH·D M MaynardW A Gahl
Oct 10, 2007·Journal of Thrombosis and Haemostasis : JTH·J W Weisel
Jun 17, 2008·Cells, Tissues, Organs·Faisal M ShaikhTim M McGloughlin
Sep 20, 2008·Journal of the Royal Society, Interface·Paul A JanmeyJohn W Weisel
Sep 30, 2010·Platelets·Valentina ParazziPaolo Rebulla
Aug 10, 2012·BMC Research Notes·Kaitlin C Murphy, J Kent Leach
Feb 20, 2015·Cell Transplantation·Valentina ParazziLorenza Lazzari
Apr 22, 2015·International Journal of Medical Sciences·Paola AulinoLaura Teodori
Sep 15, 2015·Journal of Cancer·Marco TatulloSalvatore Scacco
Jan 27, 2016·Clinical Oral Investigations·Eizaburo KobayashiRichard J Miron
Jul 6, 2016·Proteomics. Clinical Applications·Valentina LongoSara Rinalducci
Dec 3, 2016·Trends in Biotechnology·Eduardo AnituaGorka Orive
Mar 10, 2017·Platelets·Jing QiaoXiangying Ouyang
Aug 22, 2017·Journal of Proteome Research·Eva StokhuijzenAlexander Benjamin Meijer
Feb 15, 2018·Platelets·Julia Etulain
Sep 27, 2018·Bioengineering·Effrosyni PanagouliCatherine Stavropoulos-Giokas
Feb 13, 2019·International Journal of Molecular Sciences·Dorottya KardosIstván Hornyák
Apr 18, 2019·Vascular Specialist International·Maria TsachiridiKonstantinos Filis
Apr 10, 2017·ACS Biomaterials Science & Engineering·Punyavee KerativitayananAkhilesh K Gaharwar

❮ Previous
Next ❯

Software Mentioned

GraphPad Prism
Panther
Skyfline
Peptideatlas
GraphPaD
Skyline
Excel

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.